Literature DB >> 25664439

Quality of life, urogynecological morbidity, and lymphedema after radical vaginal trachelectomy for early-stage cervical cancer.

Ligita Paskeviciute Frøding1, Christian Ottosen, Berit Jul Mosgaard, Pernille Tine Jensen.   

Abstract

OBJECTIVE: Radical vaginal trachelectomy (RVT) offers a possibility for future childbearing for young women with early-stage cervical cancer. However, the literature on quality of life and self-reported morbidity in patients undergoing RVT is scarce. The aim of this study was to prospectively assess quality of life after RVT with focus on urogynecological morbidity and lymphedema. Furthermore, the aim of this study was to compare results with those in women treated with radical abdominal hysterectomy (RAH) and with age-matched control women from the general population. METHODS AND MATERIALS: Eighteen patients with early-stage cervical cancer operated with RVT were prospectively included and assessed preoperatively, 3, 6, and 12 months postoperatively using validated questionnaires. Thirty-two patients treated with RAH were included consecutively and assessed once at 12 months postsurgery, whereas an age-matched control group of 30 healthy women was assessed once.
RESULTS: Fifty percent of the RVT group and 41% of the RAH reported any grade of incomplete bladder emptying problems at 1 year postsurgery assessment. Eleven percent of the RVT patients and 12.5% of the RAH patients reported severe lymphedema of the legs as assessed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module. The Global Health Status scores of the RVT patients improved over time but were significantly lower than in the healthy controls during the entire observation time (P = 0.029).
CONCLUSIONS: Patients treated with RVT for early-stage cervical cancer had persistent bladder emptying problems and lymphedema comparable to those experienced by patients treated with RAH and significantly higher than those reported by healthy control women.

Entities:  

Mesh:

Year:  2015        PMID: 25664439     DOI: 10.1097/IGC.0000000000000395

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Quality of life after radical trachelectomy for early-stage cervical cancer: A 5-year prospective evaluation.

Authors:  N D Fleming; P T Ramirez; P T Soliman; K M Schmeler; G B Chisholm; A M Nick; S N Westin; M Frumovitz
Journal:  Gynecol Oncol       Date:  2016-10-11       Impact factor: 5.482

Review 2.  Lower extremity lymphedema in patients with gynecologic malignancies.

Authors:  Kimberly Dessources; Emeline Aviki; Mario M Leitao
Journal:  Int J Gynecol Cancer       Date:  2020-01-07       Impact factor: 3.437

3.  Prediction of rehabilitation needs after treatment of cervical cancer: what do late adverse effects tell us?

Authors:  Tina Broby Mikkelsen; Bente Sørensen; Karin B Dieperink
Journal:  Support Care Cancer       Date:  2016-11-10       Impact factor: 3.603

Review 4.  Fertility preservation in women with cervical, endometrial or ovarian cancers.

Authors:  Michael Feichtinger; Kenny A Rodriguez-Wallberg
Journal:  Gynecol Oncol Res Pract       Date:  2016-07-27

5.  Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients.

Authors:  David Cibula; Martina Borčinová; Simone Marnitz; Jiří Jarkovský; Jaroslav Klát; Radovan Pilka; Aureli Torné; Ignacio Zapardiel; Almerinda Petiz; Laura Lay; Borek Sehnal; Jordi Ponce; Michal Felsinger; Octavio Arencibia-Sánchez; Peter Kaščák; Kamil Zalewski; Jiri Presl; Alicia Palop-Moscardó; Solveig Tingulstad; Ignace Vergote; Mikuláš Redecha; Filip Frühauf; Christhardt Köhler; Roman Kocián
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.